-
Paclitaxel (Taxol) Workflows for Cancer Research
2026-09-01
Paclitaxel (Taxol) converts microtubule stabilization into measurable cell-cycle, mitotic, and apoptosis endpoints. This practical workflow helps cancer research teams optimize dosing, validate phenotypes, and evaluate paclitaxel combinations in breast cancer models without overinterpreting model-specific results.
-
Human Intestinal Organoids for Pharmacokinetic Studies
2026-09-01
Saito and colleagues developed a direct three-dimensional cluster-culture method for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids could be propagated, cryopreserved, and converted into intestinal epithelial monolayers containing metabolically and transport-competent enterocytes, providing a more human-relevant platform for oral drug pharmacokinetic studies.
-
Synthetic OLIG2 mRNA Drives Rapid hiPSC Differentiation
2026-08-31
The reference study presents a transgene-free strategy for converting human induced pluripotent stem cells into oligodendrocyte progenitor cells by repeatedly delivering synthetic modified messenger RNA encoding OLIG2S147A. Its rapid differentiation schedule, progenitor-cell yield, and subsequent functional remyelination findings make the work relevant to regenerative neuroscience and mRNA-based cellular engineering.
-
Lactate–Ran Lactylation Drives Astrocyte Polarization
2026-08-31
A 2026 study identifies Ran lactylation at lysine 123 as a non-histone mechanism linking lactate accumulation to STAT3 nuclear transport and A2 astrocyte polarization after oxygen-glucose deprivation/reoxygenation. The findings position SIRT1-regulated Ran lactylation as a mechanistic connection between metabolism and cellular responses to spinal cord injury, while also defining experimental entry points for studying this pathway.
-
Cy3 NHS ester (non-sulfonated): Practical Workflow
2026-08-30
Cy3 NHS ester (non-sulfonated) provides an orange fluorescent NHS ester for labeling accessible amino groups on proteins, peptides, and amino-modified oligonucleotides. Because it is water-insoluble and requires an organic co-solvent, it is better suited to workflows that tolerate DMSO or DMF than to delicate biomolecules requiring strictly aqueous handling.
-
Cy5.5 NHS Ester for ORP Imaging
2026-08-29
Cy5.5 NHS ester (non-sulfonated) converts amine-bearing biomolecules into near-infrared imaging probes, creating a practical route for tracking polysaccharide distribution and biomolecule fate. This guide connects the extraction and gastrointestinal-distribution findings for Oudemansiella raphanipies polysaccharides with reproducible conjugation, purification, imaging, and troubleshooting workflows.
-
Mildronate Lipidoids for Lower-Inflammation mRNA Delivery
2026-08-28
The 2024 ACS Nano study developed mildronate-derived cationic lipidoids and formulated mLNP-69 to preserve effective mRNA delivery while reducing local inflammatory effects associated with conventional lipid nanoparticles. In prophylactic and therapeutic B16OVA melanoma models, this low-lipid-dose strategy supported tumor prevention or delayed progression, providing a useful framework for safer preclinical vaccine development research.
-
BRCAness and Olaparib Sensitivity in Mesothelioma
2026-08-28
Borchert et al. integrated in vitro drug-response testing with homologous recombination repair gene-expression profiling to evaluate whether BRCAness predicts olaparib sensitivity in malignant pleural mesothelioma. Their findings support particular interest in BAP1-mutated tumors and cisplatin–olaparib combinations, while the absence of clinical validation limits immediate therapeutic interpretation.
-
Neticonazole Hydrochloride: Applied Research Workflows
2026-08-27
Neticonazole Hydrochloride connects superficial Candida models with exploratory colorectal cancer research through distinct, testable assay workflows. This guide covers sample handling, fungal cell membrane synthesis inhibition, exosome-related readouts, apoptosis analysis, formulation-aware controls, and troubleshooting without conflating topical clinical use with unapproved oncology treatment.
-
AL-8810: A Translational Lens on FP Receptor Biology
2026-08-27
AL-8810 gives translational researchers a receptor-focused way to interrogate PGF2α biology across endometrial, vascular, smooth muscle, and ocular models. This article connects recent PTGFR evidence with practical assay design, competitive positioning, and responsible translational interpretation.
-
Nigericin: From Ion Gradients to Translational Strategy
2026-08-26
Nigericin is more than a catalog ionophore: it is a mechanistic probe for connecting potassium–proton exchange with intracellular pH, mitochondrial behavior, and GSDMD-linked cell fate. This thought-leadership perspective outlines how to validate those effects, interpret Nigericin anticancer activity responsibly, and use metabolic antibiotic research to define a broader but carefully bounded translational agenda.
-
Rocilinostat (ACY-1215) Research Workflows
2026-08-26
Rocilinostat (ACY-1215) enables selective HDAC6 target engagement studies, from α-tubulin acetylation and multiple myeloma cell viability assays to proteasome-inhibitor combination experiments. This guide also shows how to extend the compound cautiously into cilia and neural-progenitor research without conflating HDAC6 activity with the SMPD4–ceramide mechanism.
-
Measuring Drug Response in Cancer In Vitro
2026-08-25
Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of an anticancer response. This framework provides a practical basis for interpreting PARP inhibitor experiments, including breast cancer studies in which DNA repair pathway modulation may produce cytostatic, cytotoxic, or temporally separated effects.
-
Afatinib (BIBW 2992) in Gastric Assembloids
2026-08-25
Afatinib (BIBW 2992) offers translational researchers a mechanistically defined way to interrogate ErbB-driven signaling in patient-derived gastric cancer assembloids. By pairing irreversible EGFR, HER2, and HER4 inhibition with matched tumor–stroma models, researchers can move beyond simplified response estimates toward context-aware cancer biology research and targeted therapy research.
-
Carbapenemase Transmission in CREC in Guangdong
2026-08-24
Chen and colleagues characterize carbapenemase-encoding genes, their chromosomal or plasmid locations, and their transfer potential in carbapenem-resistant Enterobacter cloacae collected from eight Guangdong teaching hospitals. The study links blaNDM-1 dominance and frequent conjugative transfer with multidrug resistance, while ERIC-PCR reveals both widespread genetic diversity and possible clonal overlap across hospital settings.